Pharmacotherapy before/during/after PCI

Presentations available when logged in:

• Comparing the effectiveness of oral and intravenous administration of nicorandil on coronary microcirculation in patients undergoing elective PCI:...
• Dabigatran in patients with atrial fibrillation undergoing primary PCI for STEMI - A subanalysis of the randomised RE-DUAL PCI trial
• Ticagrelor monotherapy in patients with impaired renal function treated with PCI is safe in ACS but not in stable coronary artery disease - Insight...
• Ticagrelor pre-treatment compared with treatment during percutaneous procedure in patients with STEMI undergoing primary PCI
• STEMI - When to give the loading dose of the P2Y12 inhibitor?
• First comparison of post-procedural bivalirudin infusion at full or low regimen in patients with ACS with or without STEMI: an analysis of the MATR...
• Six vs. twelve months of DAPT in myocardial infarction patients undergoing PCI with second-generation DES: a pooled database analysis from SMART-DA...